RdRP-IN-6

RdRP-IN-6

• UNSPSC Description: RdRP-IN-6 (compound 27) inhibits RNA dependent-RNA polymerase (RdRp) with an IC90 value of 14.1 μM. RdRP-IN-6 can be used for research on antiviral and anticancer[1].
• Target Antigen: DNA/RNA Synthesis
• Type: Reference compound
• Related Pathways: Cell Cycle/DNA Damage
• Applications: COVID-19-anti-virus
• Field of Research: Cancer; Infection
• Assay Protocol: https://www.medchemexpress.com/rdrp-in-6.html
• Solubility: 10 mM in DMSO
• Smiles: O=[P@@](N[C@H](C(OCC(CC)CC)=O)C)(OC[C@@H]1[C@@H](O[Si](C(C)(C)C)(C)C)[C@H](O[Si](C(C)(C)C)(C)C)[C@](C2=CNN=N2)(C3=CC=C4C(N)=NC=NN34)C1)OC5=CC=CC=C5
• Molecular Weight: 871.16
• References & Citations: [1]Cardoza S, et al. Multistep Synthesis of Analogues of Remdesivir: Incorporating Heterocycles at the C-1' Position. J Org Chem. 2023 Jul 7;88(13):9105-9122.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported